View Item 

Show simple item record

Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir
dc.contributor.authorNicolasora, N. P.en_US
dc.contributor.authorReddy, P.en_US
dc.contributor.authorKaul, D. R.en_US
dc.date.accessioned2010-06-01T19:57:40Z
dc.date.available2010-06-01T19:57:40Z
dc.date.issued2008-10en_US
dc.identifier.citationNicolasora, N.P.; Reddy, P.; Kaul, D.R. (2008). "Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir." Transplant Infectious Disease 10(5): 346-350. <http://hdl.handle.net/2027.42/73090>en_US
dc.identifier.issn1398-2273en_US
dc.identifier.issn1399-3062en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73090
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18282236&dopt=citationen_US
dc.description.abstractWe present a case of diarrhea secondary to biopsy-proven adenovirus (ADV) infection after autologous peripheral hematopoietic stem cell transplant for multiple myeloma. The patient had a negative plasma polymerase chain reaction for ADV and a dramatic clinical response to low-dose cidofovir. To our knowledge, this is the first report in an adult hematopoietic stem cell recipient of the use of low-dose cidofovir to treat proven ADV gastrointestinal infection.en_US
dc.format.extent728347 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2008 Wiley Periodicals, Inc.en_US
dc.subject.otherAdenovirusen_US
dc.subject.otherDiarrheaen_US
dc.subject.otherStem Cell Transplanten_US
dc.subject.otherLow-dose Cidofoviren_US
dc.titleBiopsy-proven adenoviral diarrhea responding to low-dose cidofoviren_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA anden_US
dc.contributor.affiliationumBlood and Bone Marrow Transplant Program, Department of Internal Medicine, Division of Hematology-Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid18282236en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73090/1/j.1399-3062.2008.00303.x.pdf
dc.identifier.doi10.1111/j.1399-3062.2008.00303.xen_US
dc.identifier.sourceTransplant Infectious Diseaseen_US
dc.identifier.citedreferenceShields AF, Hackman RC, Fife KH, et al. Adenovirus infections in patients undergoing bone marrow transplantation. N Engl J Med 1985; 312: 529 – 533.en_US
dc.identifier.citedreferenceFlomenberg P, Babbitt J, Drobyski WR, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994; 169: 775 – 781.en_US
dc.identifier.citedreferenceBlanke C, Clark C, Broun R, et al. Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections. Am J Med 1995; 99: 326 – 368.en_US
dc.identifier.citedreferenceMunoz FM, Piedra PA, Demmler GJ. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis 1998; 27: 1194 – 1200.en_US
dc.identifier.citedreferenceHale GA, Heslop HE, Krance RA, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999; 23: 277 – 282.en_US
dc.identifier.citedreferenceHoward DS, Phillips GL, Reece DE, et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 1999; 29: 1494 – 1501.en_US
dc.identifier.citedreferenceBaldwin A, Kingman H, Darville M, et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000; 26: 1333 – 1338.en_US
dc.identifier.citedreferenceRunde V, Ross S, Trenschel R, et al. Adenoviral infection after allogeneic stem cell transplantation: report on 130 patients from a single SCT unit involved in a prospective multicenter surveillance study. Bone Marrow Transplant 2001; 28: 51 – 57.en_US
dc.identifier.citedreferenceHoffman JA, Shah AJ, Ross LA, et al. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 388 – 394.en_US
dc.identifier.citedreferenceLa Rosa AM, Champlin RE, Mirza N, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001; 32: 871 – 876.en_US
dc.identifier.citedreferenceChakrabarti S, Mautner V, Osman H, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002; 100: 1619 – 1627.en_US
dc.identifier.citedreferenceBruno B, Gooley T, Hackman RC, et al. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant 2003; 9: 341 – 352.en_US
dc.identifier.citedreferenceLion T, Baumgartinger R, Watzinger F, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003; 102: 1114 – 1120.en_US
dc.identifier.citedreferenceHumar A, Kumar D, Mazzulli T, et al. A surveillance study of adenovirus infection in adult solid-organ transplant recipients. Am J Transplant 2005; 5: 2555 – 2559.en_US
dc.identifier.citedreferenceSymeonidis N, Jakubowski A, Pierre-Louis S, et al. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis 2007; 9: 108 – 113.en_US
dc.identifier.citedreferenceWalls T, Hawrami K, Ushiro-Lumb I, et al. Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary? Clin Infect Dis 2005; 40: 1244 – 1249.en_US
dc.identifier.citedreferenceKampmann B, Cubitt D, Walls T, et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005; 130: 595 – 603.en_US
dc.identifier.citedreferenceLegrand F, Berrebi D, Houhou N, et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 2001; 27: 621 – 626.en_US
dc.identifier.citedreferenceNeofytos D, Ojhal A, Mokerjee B, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 2007; 13: 74 – 81.en_US
dc.identifier.citedreferenceLjungman P, Ribaud P, Eyrich M, et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003; 31: 4816.en_US
dc.identifier.citedreferenceLeruez-Ville M, Minard V, Lacaille F, et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis 2004; 38: 45 – 52.en_US
dc.identifier.citedreferenceMuller WJ, Levin MJ, Shin YK, et al. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis 2005; 41: 1812 – 1816.en_US
dc.identifier.citedreferenceHatakeyama N, Suzuki N, Kudoh T, et al. Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant. Pediatr Infect Dis J 2003; 22: 928 – 929.en_US
dc.identifier.citedreferenceNagafuji K, Aoki K, Henzan H, et al. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2004; 34: 909 – 914.en_US
dc.identifier.citedreferenceIson MG. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43: 331 – 339.en_US
dc.identifier.citedreferenceChakrabarti S, Collingham KE, Stevens RH, et al. Isolation of viruses from stools in stem cell recipients: prospective surveillance study. Bone Marrow Transplant 2000; 25: 277 – 182.en_US
dc.identifier.citedreferenceCox GJ, Matsui SM, Lo RS, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 1994; 107: 1398 – 1407.en_US
dc.identifier.citedreferenceChakrabarti S, Collingham KE, Fegan CD, et al. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplant 2000; 26: 305 – 307.en_US
dc.identifier.citedreferenceAvivi I, Chakrabarti S, Milligan DW, et al. Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. Biol Blood Marrow Transplant 2004; 10: 186 – 194.en_US
dc.identifier.citedreferenceFeuchtinger T, Lucke J, Hamprecht K, et al. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2005; 128: 503 – 509.en_US
dc.identifier.citedreferenceHeemskerk B, Lankester AC, van Vreeswijk T, et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis 2005; 191: 520 – 530.en_US
dc.identifier.citedreferenceHromas R, Cornetta K, Srour E, Blanke C, Broun ER. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 1994; 84: 1689 – 1690.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1399-3062.2008.00303.x.pdf
Size:
711.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.